Deutsche Bank Ag\ Syros Pharmaceuticals, Inc. Transaction History

Deutsche Bank Ag\

  • $240 Billion
  • Q3 2024

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 11, 2022
SELL
$0.69 - $1.21 $22,883 - $40,128
-33,164 Closed
0 $0
Q1 2022

May 13, 2022
SELL
$1.02 - $3.8 $3,792 - $14,128
-3,718 Reduced 10.08%
33,164 $39,000
Q4 2021

Feb 11, 2022
SELL
$3.26 - $4.66 $75,276 - $107,604
-23,091 Reduced 38.5%
36,882 $120,000
Q3 2021

Nov 04, 2021
BUY
$4.08 - $5.66 $97,165 - $134,792
23,815 Added 65.86%
59,973 $268,000
Q2 2021

Aug 11, 2021
SELL
$5.01 - $7.48 $100,345 - $149,816
-20,029 Reduced 35.65%
36,158 $196,000
Q1 2021

May 13, 2021
BUY
$7.19 - $14.95 $180,670 - $375,663
25,128 Added 80.9%
56,187 $420,000
Q4 2020

Feb 16, 2021
BUY
$6.66 - $14.66 $53,413 - $117,573
8,020 Added 34.81%
31,059 $337,000
Q3 2020

Nov 12, 2020
BUY
$8.69 - $14.47 $17,449 - $29,055
2,008 Added 9.55%
23,039 $204,000
Q2 2020

Aug 13, 2020
BUY
$5.21 - $11.03 $47,598 - $100,770
9,136 Added 76.81%
21,031 $224,000
Q1 2020

May 14, 2020
SELL
$4.46 - $9.2 $32,335 - $66,700
-7,250 Reduced 37.87%
11,895 $70,000
Q4 2019

Feb 14, 2020
SELL
$4.52 - $10.1 $177,089 - $395,707
-39,179 Reduced 67.17%
19,145 $131,000
Q3 2019

Nov 14, 2019
SELL
$7.14 - $11.65 $231,935 - $378,438
-32,484 Reduced 35.77%
58,324 $604,000
Q2 2019

Aug 14, 2019
BUY
$5.5 - $9.75 $335,863 - $595,393
61,066 Added 205.32%
90,808 $838,000
Q1 2019

May 15, 2019
SELL
$5.51 - $9.59 $88,193 - $153,497
-16,006 Reduced 34.99%
29,742 $269,000
Q4 2018

Feb 14, 2019
SELL
$5.55 - $11.34 $162,809 - $332,658
-29,335 Reduced 39.07%
45,748 $254,000
Q3 2018

Dec 21, 2021
BUY
$9.74 - $12.92 $64,917 - $86,111
6,665 Added 9.74%
75,083 $894,000
Q3 2018

Nov 14, 2018
SELL
$9.74 - $12.92 $1.36 Million - $1.81 Million
-140,095 Reduced 67.19%
68,418 $813,000
Q2 2018

Apr 21, 2020
BUY
$10.16 - $13.65 $80,751 - $108,490
7,948 Added 3.96%
208,513 $2.13 Million
Q2 2018

Aug 14, 2018
BUY
$10.16 - $13.65 $1.84 Million - $2.47 Million
180,622 Added 905.69%
200,565 $2.05 Million
Q1 2018

Oct 18, 2019
BUY
$9.47 - $12.98 $34,480 - $47,260
3,641 Added 22.33%
19,943 $258,000
Q1 2018

May 15, 2018
SELL
$9.47 - $12.98 $107,077 - $146,764
-11,307 Reduced 40.95%
16,302 $211,000
Q4 2017

Feb 14, 2018
SELL
$8.45 - $17.48 $66,586 - $137,742
-7,880 Reduced 22.2%
27,609 $267,000
Q3 2017

Nov 14, 2017
BUY
$13.52 - $23.75 $479,811 - $842,863
35,489
35,489 $520,000

About Syros Pharmaceuticals, Inc.

SYRS Quotes by TradingView
  • Ticker SYRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 20,236,200
  • Market Cap $4.25M
  • Description
  • Syros Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of treatments for cancer and monogenic diseases, and building a pipeline of gene control medicines. The company's lead product candidates are Tamibarotene, a selective retinoic acid receptor alpha agonist, which is in Phase III clinical trial for genomically def...
More about SYRS
Track This Portfolio

Track Deutsche Bank Ag\ Portfolio

Follow Deutsche Bank Ag\ and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email